Cargando…
Carcinoid Syndrome: A Review
Carcinoid syndrome (CS) is a paraneoplastic syndrome caused by the release of serotonin and other substances from well-differentiated neuroendocrine tumors (NETs). The hallmark symptoms of carcinoid syndrome are flushing and diarrhea; atypical signs and symptoms can include wheezing, abdominal pain,...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124884/ https://www.ncbi.nlm.nih.gov/pubmed/32257725 http://dx.doi.org/10.7759/cureus.7186 |
_version_ | 1783515851724423168 |
---|---|
author | Gade, Ajay K Olariu, Eva Douthit, Nathan T |
author_facet | Gade, Ajay K Olariu, Eva Douthit, Nathan T |
author_sort | Gade, Ajay K |
collection | PubMed |
description | Carcinoid syndrome (CS) is a paraneoplastic syndrome caused by the release of serotonin and other substances from well-differentiated neuroendocrine tumors (NETs). The hallmark symptoms of carcinoid syndrome are flushing and diarrhea; atypical signs and symptoms can include wheezing, abdominal pain, valvular heart disease, telangiectasias, pellagra, and the complications of mesenteric fibrosis, including ureteral obstruction, bowel obstruction, and bowel ischemia. These symptoms are mediated by the release of serotonin (5-HT), histamine, kallikrein, prostaglandins, and tachykinins. The diagnosis of CS requires these symptoms and corresponding elevations in lab tests. Treatment options include surgery and medical management with somatostatin analogs. |
format | Online Article Text |
id | pubmed-7124884 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-71248842020-04-06 Carcinoid Syndrome: A Review Gade, Ajay K Olariu, Eva Douthit, Nathan T Cureus Gastroenterology Carcinoid syndrome (CS) is a paraneoplastic syndrome caused by the release of serotonin and other substances from well-differentiated neuroendocrine tumors (NETs). The hallmark symptoms of carcinoid syndrome are flushing and diarrhea; atypical signs and symptoms can include wheezing, abdominal pain, valvular heart disease, telangiectasias, pellagra, and the complications of mesenteric fibrosis, including ureteral obstruction, bowel obstruction, and bowel ischemia. These symptoms are mediated by the release of serotonin (5-HT), histamine, kallikrein, prostaglandins, and tachykinins. The diagnosis of CS requires these symptoms and corresponding elevations in lab tests. Treatment options include surgery and medical management with somatostatin analogs. Cureus 2020-03-05 /pmc/articles/PMC7124884/ /pubmed/32257725 http://dx.doi.org/10.7759/cureus.7186 Text en Copyright © 2020, Gade et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Gastroenterology Gade, Ajay K Olariu, Eva Douthit, Nathan T Carcinoid Syndrome: A Review |
title | Carcinoid Syndrome: A Review |
title_full | Carcinoid Syndrome: A Review |
title_fullStr | Carcinoid Syndrome: A Review |
title_full_unstemmed | Carcinoid Syndrome: A Review |
title_short | Carcinoid Syndrome: A Review |
title_sort | carcinoid syndrome: a review |
topic | Gastroenterology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124884/ https://www.ncbi.nlm.nih.gov/pubmed/32257725 http://dx.doi.org/10.7759/cureus.7186 |
work_keys_str_mv | AT gadeajayk carcinoidsyndromeareview AT olariueva carcinoidsyndromeareview AT douthitnathant carcinoidsyndromeareview |